-
1
-
-
0024449985
-
High-density lipoprotein--the clinical implications of recent studies
-
Gordon DJ, Rifkind BM. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med 1989; 321: 1311-6.
-
(1989)
N Engl J Med
, vol.321
, pp. 1311-1316
-
-
Gordon, D.J.1
Rifkind, B.M.2
-
2
-
-
43449085800
-
Laboratory assessment of HDL heterogeneity and function
-
Movva R, Rader DJ. Laboratory assessment of HDL heterogeneity and function. Clin Chem 2008; 54: 788-800.
-
(2008)
Clin Chem
, vol.54
, pp. 788-800
-
-
Movva, R.1
Rader, D.J.2
-
3
-
-
0028925078
-
Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
-
Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96.
-
(1995)
Circulation
, vol.91
, pp. 2488-2496
-
-
Berliner, J.A.1
Navab, M.2
Fogelman, A.M.3
-
4
-
-
0038120897
-
ABCA1-deficient mice: Insights into the role of monocyte lipid efflux in HDL formation and inflammation
-
Aiello RJ, Brees D, Francone OL. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 2003; 23: 972-80.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 972-980
-
-
Aiello, R.J.1
Brees, D.2
Francone, O.L.3
-
5
-
-
0038028612
-
HDL apolipoproteins and ABCA1: Partners in the removal of excess cellular cholesterol
-
Oram JF. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 2003; 23: 720-7.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 720-727
-
-
Oram, J.F.1
-
6
-
-
0036301461
-
Increased ABCA1 activity protects against atherosclerosis
-
Singaraja RR, Fievet C, Castro G, et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002; 110: 35-42.
-
(2002)
J Clin Invest
, vol.110
, pp. 35-42
-
-
Singaraja, R.R.1
Fievet, C.2
Castro, G.3
-
7
-
-
33845580066
-
ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL
-
Vaughan AM, Oram JF. ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J Lipid Res 2006; 47: 2433-43.
-
(2006)
J Lipid Res
, vol.47
, pp. 2433-2443
-
-
Vaughan, A.M.1
Oram, J.F.2
-
8
-
-
0142042380
-
ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions
-
Vaughan AM, Oram JF. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res 2003; 44: 1373-80.
-
(2003)
J Lipid Res
, vol.44
, pp. 1373-1380
-
-
Vaughan, A.M.1
Oram, J.F.2
-
9
-
-
0028060613
-
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol
-
Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest; 94: 1698-705.
-
J Clin Invest
, vol.94
, pp. 1698-1705
-
-
Mendez, A.J.1
Anantharamaiah, G.M.2
Segrest, J.P.3
Oram, J.F.4
-
10
-
-
0037085289
-
Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATPbinding cassette transporter A1
-
Wang Y, Oram JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATPbinding cassette transporter A1. J Biol Chem 2002; 277: 5692-7.
-
(2002)
J Biol Chem
, vol.277
, pp. 5692-5697
-
-
Wang, Y.1
Oram, J.F.2
-
11
-
-
6344253356
-
Antiinflammatory properties of HDL
-
Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004; 95: 764-72.
-
(2004)
Circ Res
, vol.95
, pp. 764-772
-
-
Barter, P.J.1
Nicholls, S.2
Rye, K.A.3
Anantharamaiah, G.M.4
Navab, M.5
Fogelman, A.M.6
-
12
-
-
0037177140
-
High-density lipoprotein restores endothelial function in hypercholesterolemic men
-
Spieker LE, Sudano I, Hurlimann D, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105: 1399-402.
-
(2002)
Circulation
, vol.105
, pp. 1399-1402
-
-
Spieker, L.E.1
Sudano, I.2
Hurlimann, D.3
-
13
-
-
0034607112
-
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits
-
Mackness M, Boullier A, Hennuyer N, et al. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun 2000; 269: 232-6.
-
(2000)
Biochem Biophys Res Commun
, vol.269
, pp. 232-236
-
-
Mackness, M.1
Boullier, A.2
Hennuyer, N.3
-
15
-
-
0027279942
-
Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
-
Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993; 261: 469-72.
-
(1993)
Science
, vol.261
, pp. 469-472
-
-
Warden, C.H.1
Hedrick, C.C.2
Qiao, J.H.3
Castellani, L.W.4
Lusis, A.J.5
-
16
-
-
0037155049
-
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice
-
Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90: 270-6.
-
(2002)
Circ Res
, vol.90
, pp. 270-276
-
-
Braun, A.1
Trigatti, B.L.2
Post, M.J.3
-
17
-
-
0036790522
-
Regulation and mechanisms of macrophage cholesterol efflux
-
Tall AR, Costet P, Wang N. Regulation and mechanisms of macrophage cholesterol efflux. J Clin Invest 2002; 110: 899-904.
-
(2002)
J Clin Invest
, vol.110
, pp. 899-904
-
-
Tall, A.R.1
Costet, P.2
Wang, N.3
-
18
-
-
0041527450
-
Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells
-
Covey SD, Krieger M, Wang W, Penman M, Trigatti BL. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23: 1589-94.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1589-1594
-
-
Covey, S.D.1
Krieger, M.2
Wang, W.3
Penman, M.4
Trigatti, B.L.5
-
19
-
-
78651379500
-
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
-
Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364: 127-35.
-
(2011)
N Engl J Med
, vol.364
, pp. 127-135
-
-
Khera, A.V.1
Cuchel, M.2
de la Llera-Moya, M.3
-
20
-
-
36148937168
-
Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans
-
Vaisar T, Shao B, Green PS, Oda MN, Oram JF, Heinecke JW. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans. Curr Atheroscler Rep 2007; 9: 417-24.
-
(2007)
Curr Atheroscler Rep
, vol.9
, pp. 417-424
-
-
Vaisar, T.1
Shao, B.2
Green, P.S.3
Oda, M.N.4
Oram, J.F.5
Heinecke, J.W.6
-
21
-
-
4444292600
-
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
-
Bergt C, Pennathur S, Fu X, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 2004; 101: 13032-7.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 13032-13037
-
-
Bergt, C.1
Pennathur, S.2
Fu, X.3
-
22
-
-
27744572151
-
Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I
-
Shao B, Fu X, McDonald TO, et al. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J Biol Chem 2005; 280: 36386-96.
-
(2005)
J Biol Chem
, vol.280
, pp. 36386-36396
-
-
Shao, B.1
Fu, X.2
McDonald, T.O.3
-
23
-
-
12844266113
-
Formation of methionine sulfoxidecontaining specific forms of oxidized high-density lipoproteins
-
Panzenböck U, Stocker R. Formation of methionine sulfoxidecontaining specific forms of oxidized high-density lipoproteins. Biochim Biophys Acta 2005; 1703: 171-81.
-
(2005)
Biochim Biophys Acta
, vol.1703
, pp. 171-181
-
-
Panzenböck, U.1
Stocker, R.2
-
24
-
-
4344577056
-
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
-
Zheng L, Nukuna B, Brennan ML, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004; 114: 529-41.
-
(2004)
J Clin Invest
, vol.114
, pp. 529-541
-
-
Zheng, L.1
Nukuna, B.2
Brennan, M.L.3
-
25
-
-
0033973485
-
High density lipoprotein oxidation: In vitro susceptibility and potential in vivo consequences
-
Francis GA. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 2000; 1483: 217-35.
-
(2000)
Biochim Biophys Acta
, vol.1483
, pp. 217-235
-
-
Francis, G.A.1
-
26
-
-
44649140474
-
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
-
Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008; 299: 2524-32.
-
(2008)
JAMA
, vol.299
, pp. 2524-2532
-
-
Frikke-Schmidt, R.1
Nordestgaard, B.G.2
Stene, M.C.3
-
27
-
-
69849109122
-
Update on strategies to increase HDL quantity and function
-
Duffy D, Rader DJ. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 2009; 6: 455-63.
-
(2009)
Nat Rev Cardiol
, vol.6
, pp. 455-463
-
-
Duffy, D.1
Rader, D.J.2
-
28
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-22.
-
(2007)
N Engl J Med
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
-
30
-
-
79952222810
-
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events
-
Rosenson RS, Brewer HB Jr, Chapman MJ, et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 2011; 57: 392-410.
-
(2011)
Clin Chem
, vol.57
, pp. 392-410
-
-
Rosenson, R.S.1
Brewer Jr., H.B.2
Chapman, M.J.3
-
31
-
-
0022556171
-
Precipitation methods for quantification of lipoproteins
-
Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol 1986; 129: 78-100.
-
(1986)
Methods Enzymol
, vol.129
, pp. 78-100
-
-
Bachorik, P.S.1
Albers, J.J.2
-
32
-
-
0019855909
-
Multilaboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates
-
Warnick GR, Albers JJ, Bachorik PS, et al. Multilaboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates. J Lipid Res 1981; 22: 1015-20.
-
(1981)
J Lipid Res
, vol.22
, pp. 1015-1020
-
-
Warnick, G.R.1
Albers, J.J.2
Bachorik, P.S.3
-
33
-
-
33745026603
-
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
-
Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-53.
-
(1955)
J Clin Invest
, vol.34
, pp. 1345-1353
-
-
Havel, R.J.1
Eder, H.A.2
Bragdon, J.H.3
-
34
-
-
2542418747
-
The concept of apolipoprotein-defined lipoprotein families and its clinical significance
-
Alaupovic P. The concept of apolipoprotein-defined lipoprotein families and its clinical significance. Curr Atheroscler Rep 2003; 5: 459-67.
-
(2003)
Curr Atheroscler Rep
, vol.5
, pp. 459-467
-
-
Alaupovic, P.1
-
35
-
-
0029589645
-
Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins
-
Alaupovic P. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Methods Enzymol 1996; 263: 32-60.
-
(1996)
Methods Enzymol
, vol.263
, pp. 32-60
-
-
Alaupovic, P.1
-
36
-
-
0015452452
-
Peptide composition of human plasma apolipoproteins A, B and C
-
Alaupovic P, Kostner G, Lee DM, McConathy WJ, Magnani HN. Peptide composition of human plasma apolipoproteins A, B and C. Expos Annu Biochim Med 1972; 31: 145-60.
-
(1972)
Expos Annu Biochim Med
, vol.31
, pp. 145-160
-
-
Alaupovic, P.1
Kostner, G.2
Lee, D.M.3
McConathy, W.J.4
Magnani, H.N.5
-
37
-
-
0017640673
-
The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay
-
Cheung MC, Albers JJ. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest 1977; 60: 43-50.
-
(1977)
J Clin Invest
, vol.60
, pp. 43-50
-
-
Cheung, M.C.1
Albers, J.J.2
-
38
-
-
0016165743
-
The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay
-
Schonfeld G, Pfleger B. The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay. J Clin Invest 1974; 54: 236-46.
-
(1974)
J Clin Invest
, vol.54
, pp. 236-246
-
-
Schonfeld, G.1
Pfleger, B.2
-
39
-
-
0032254540
-
Preparative isolation of plasma lipoproteins using fast protein liquid chromatography (FPLC)
-
Ordovas JM, Osgood D. Preparative isolation of plasma lipoproteins using fast protein liquid chromatography (FPLC). Methods Mol Biol 1998; 110: 105-11.
-
(1998)
Methods Mol Biol
, vol.110
, pp. 105-111
-
-
Ordovas, J.M.1
Osgood, D.2
-
40
-
-
0032789901
-
Analysis of apolipoproteins and lipoproteins by capillary electrophoresis
-
Stocks J, Miller NE. Analysis of apolipoproteins and lipoproteins by capillary electrophoresis. Electrophoresis 1999; 20: 2118-23.
-
(1999)
Electrophoresis
, vol.20
, pp. 2118-2123
-
-
Stocks, J.1
Miller, N.E.2
-
41
-
-
0021953305
-
Analytical capillary isotachophoresis: A routine technique for the analysis of lipoproteins and lipoprotein subfractions in whole serum
-
Schmitz G, Borgmann U, Assmann G. Analytical capillary isotachophoresis: a routine technique for the analysis of lipoproteins and lipoprotein subfractions in whole serum. J Chromatogr 1985; 320: 253-62.
-
(1985)
J Chromatogr
, vol.320
, pp. 253-262
-
-
Schmitz, G.1
Borgmann, U.2
Assmann, G.3
-
42
-
-
0343953443
-
Preparative freesolution isotachophoresis for separation of human plasma lipoproteins: Apolipoprotein and lipid composition of HDL subfractions
-
Bottcher A, Schlosser J, Kronenberg F, et al. Preparative freesolution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions. J Lipid Res 2000; 41: 905-15.
-
(2000)
J Lipid Res
, vol.41
, pp. 905-915
-
-
Bottcher, A.1
Schlosser, J.2
Kronenberg, F.3
-
43
-
-
0024289037
-
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons
-
Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988; 60: 2299-301.
-
(1988)
Anal Chem
, vol.60
, pp. 2299-2301
-
-
Karas, M.1
Hillenkamp, F.2
-
44
-
-
0024438708
-
Electrospray ionization for mass spectrometry of large biomolecules
-
Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989; 246: 64-71.
-
(1989)
Science
, vol.246
, pp. 64-71
-
-
Fenn, J.B.1
Mann, M.2
Meng, C.K.3
Wong, S.F.4
Whitehouse, C.M.5
-
45
-
-
70350362707
-
Lipoproteomics: Using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins
-
Hoofnagle AN, Heinecke JW. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res 2009; 50: 1967-75.
-
(2009)
J Lipid Res
, vol.50
, pp. 1967-1975
-
-
Hoofnagle, A.N.1
Heinecke, J.W.2
-
46
-
-
0027972698
-
Standardization of Lp(a) measurements
-
Albers JJ, Marcovina SM. Standardization of Lp(a) measurements. Chem Phys Lipids 1994; 67-68: 257-63.
-
(1994)
Chem Phys Lipids
, vol.67-68
, pp. 257-263
-
-
Albers, J.J.1
Marcovina, S.M.2
-
47
-
-
0030054131
-
Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: Evaluation of amino acid analysis data
-
Albers JJ, Kennedy H, Marcovina SM. Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data. J Lipid Res 1996; 37: 192-6.
-
(1996)
J Lipid Res
, vol.37
, pp. 192-196
-
-
Albers, J.J.1
Kennedy, H.2
Marcovina, S.M.3
-
48
-
-
0020383406
-
Factors affecting the integrity of high density lipoproteins in the ultracentrifuge
-
Kunitake ST, Kane JP. Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res 1982; 23: 936-40.
-
(1982)
J Lipid Res
, vol.23
, pp. 936-940
-
-
Kunitake, S.T.1
Kane, J.P.2
-
49
-
-
38949111042
-
Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr
-
Stahlman M, Davidsson P, Kanmert I, et al. Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J Lipid Res 2008; 49: 481-90.
-
(2008)
J Lipid Res
, vol.49
, pp. 481-490
-
-
Stahlman, M.1
Davidsson, P.2
Kanmert, I.3
-
50
-
-
77956041498
-
Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation
-
Cheung MC, Vaisar T, Han X, Heinecke JW, Albers JJ. Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. Biochemistry 2010; 49: 7314-22.
-
(2010)
Biochemistry
, vol.49
, pp. 7314-7322
-
-
Cheung, M.C.1
Vaisar, T.2
Han, X.3
Heinecke, J.W.4
Albers, J.J.5
-
51
-
-
76549121693
-
Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry
-
Collins LA, Mirza SP, Kissebah AH, Olivier M. Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry. Physiol Genomics 2010; 40: 208-15.
-
(2010)
Physiol Genomics
, vol.40
, pp. 208-215
-
-
Collins, L.A.1
Mirza, S.P.2
Kissebah, A.H.3
Olivier, M.4
-
52
-
-
77955011158
-
Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry
-
Collins LA, Olivier M. Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry. Proteome Sci 2010; 8: 42.
-
(2010)
Proteome Sci
, vol.8
, pp. 42
-
-
Collins, L.A.1
Olivier, M.2
-
53
-
-
77957340934
-
Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography
-
Gordon SM, Deng J, Lu LJ, Davidson WS. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J Proteome Res 2010; 9: 5239-49.
-
(2010)
J Proteome Res
, vol.9
, pp. 5239-5249
-
-
Gordon, S.M.1
Deng, J.2
Lu, L.J.3
Davidson, W.S.4
-
54
-
-
17044423032
-
Lipoproteomics II: Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
-
Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005; 5: 1431-45.
-
(2005)
Proteomics
, vol.5
, pp. 1431-1445
-
-
Karlsson, H.1
Leanderson, P.2
Tagesson, C.3
Lindahl, M.4
-
55
-
-
32144455084
-
Proteomic analysis of high-density lipoprotein
-
Rezaee F, Casetta B, Levels JH, Speijer D, Meijers JC. Proteomic analysis of high-density lipoprotein. Proteomics 2006; 6: 721-30.
-
(2006)
Proteomics
, vol.6
, pp. 721-730
-
-
Rezaee, F.1
Casetta, B.2
Levels, J.H.3
Speijer, D.4
Meijers, J.C.5
-
56
-
-
33847368173
-
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
-
Vaisar T, Pennathur S, Green PS, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007; 117: 746-56.
-
(2007)
J Clin Invest
, vol.117
, pp. 746-756
-
-
Vaisar, T.1
Pennathur, S.2
Green, P.S.3
-
57
-
-
35348926862
-
SELDITOF mass spectrometry of high-density lipoprotein
-
Levels JH, Bleijlevens B, Rezaee F, Aerts JM, Meijers JC. SELDITOF mass spectrometry of high-density lipoprotein. Proteome Sci 2007; 5: 15.
-
(2007)
Proteome Sci
, vol.5
, pp. 15
-
-
Levels, J.H.1
Bleijlevens, B.2
Rezaee, F.3
Aerts, J.M.4
Meijers, J.C.5
-
58
-
-
77952366352
-
Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry
-
Mazur MT, Cardasis HL, Spellman DS, Liaw A, Yates NA, Hendrickson RC. Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry. Proc Natl Acad Sci USA 2010; 107: 7728-33.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 7728-7733
-
-
Mazur, M.T.1
Cardasis, H.L.2
Spellman, D.S.3
Liaw, A.4
Yates, N.A.5
Hendrickson, R.C.6
-
59
-
-
22044449637
-
Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins
-
Heller M, Stalder D, Schlappritzi E, Hayn G, Matter U, Haeberli A. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins. Proteomics 2005; 5: 2619-30.
-
(2005)
Proteomics
, vol.5
, pp. 2619-2630
-
-
Heller, M.1
Stalder, D.2
Schlappritzi, E.3
Hayn, G.4
Matter, U.5
Haeberli, A.6
-
60
-
-
49449105661
-
Guidelines for reporting the use of mass spectrometry in proteomics
-
Taylor CF, Binz PA, Aebersold R, et al. Guidelines for reporting the use of mass spectrometry in proteomics. Nat Biotechnol 2008; 26: 860-1.
-
(2008)
Nat Biotechnol
, vol.26
, pp. 860-861
-
-
Taylor, C.F.1
Binz, P.A.2
Aebersold, R.3
-
61
-
-
38649126540
-
What's driving false discovery rates?
-
Tabb DL. What's driving false discovery rates? J Proteome Res 2008; 7: 45-6.
-
(2008)
J Proteome Res
, vol.7
, pp. 45-46
-
-
Tabb, D.L.1
-
62
-
-
0033806256
-
Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides
-
Chen N, Liu Y, Greiner CD, Holtzman JL. Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 2000; 136: 58-65.
-
(2000)
J Lab Clin Med
, vol.136
, pp. 58-65
-
-
Chen, N.1
Liu, Y.2
Greiner, C.D.3
Holtzman, J.L.4
-
64
-
-
0023278621
-
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of plateletactivating factor
-
Stafforini DM, McIntyre TM, Carter ME, Prescott SM. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of plateletactivating factor. J Biol Chem 1987; 262: 4215-22.
-
(1987)
J Biol Chem
, vol.262
, pp. 4215-4222
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Carter, M.E.3
Prescott, S.M.4
-
65
-
-
67650563915
-
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1 containing particles and influence the inflammatory properties and function of high density lipoprotein
-
Watanabe J, Grijalva V, Hama S, et al. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1 containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem 2009; 284: 18292-301.
-
(2009)
J Biol Chem
, vol.284
, pp. 18292-18301
-
-
Watanabe, J.1
Grijalva, V.2
Hama, S.3
-
66
-
-
12944295219
-
The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins
-
O'Brien PJ, Alborn WE, Sloan JH, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005; 51: 351-9.
-
(2005)
Clin Chem
, vol.51
, pp. 351-359
-
-
O'Brien, P.J.1
Alborn, W.E.2
Sloan, J.H.3
-
67
-
-
0027161044
-
Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-Icontaining subpopulations
-
Asztalos BF, Sloop CH, Wong L, Roheim PS. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-Icontaining subpopulations. Biochim Biophys Acta 1993; 1169: 291-300.
-
(1993)
Biochim Biophys Acta
, vol.1169
, pp. 291-300
-
-
Asztalos, B.F.1
Sloop, C.H.2
Wong, L.3
Roheim, P.S.4
-
68
-
-
0020447101
-
Distribution of high density lipoprotein particles with different apoprotein composition: Particles with A-I and A-II and particles with A-I but no A-II
-
Cheung MC, Albers JJ. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res 1982;23: 747-53.
-
(1982)
J Lipid Res
, vol.23
, pp. 747-753
-
-
Cheung, M.C.1
Albers, J.J.2
-
69
-
-
25444468813
-
Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes
-
Shiflett AM, Bishop JR, Pahwa A, Hajduk SL. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J Biol Chem 2005; 280: 32578-85.
-
(2005)
J Biol Chem
, vol.280
, pp. 32578-32585
-
-
Shiflett, A.M.1
Bishop, J.R.2
Pahwa, A.3
Hajduk, S.L.4
-
70
-
-
0037422045
-
Apolipoprotein L-I is the trypanosome lytic factor of human serum
-
Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003; 422: 83-7.
-
(2003)
Nature
, vol.422
, pp. 83-87
-
-
Vanhamme, L.1
Paturiaux-Hanocq, F.2
Poelvoorde, P.3
-
71
-
-
0020522710
-
Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma
-
Tall AR, Forester LR, Bongiovanni GL. Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. J Lipid Res 1983; 24: 277-89.
-
(1983)
J Lipid Res
, vol.24
, pp. 277-289
-
-
Tall, A.R.1
Forester, L.R.2
Bongiovanni, G.L.3
-
72
-
-
66349083560
-
Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: Relevance to antioxidative function
-
Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 2009; 29: 870-6.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 870-876
-
-
Davidson, W.S.1
Silva, R.A.2
Chantepie, S.3
Lagor, W.R.4
Chapman, M.J.5
Kontush, A.6
-
73
-
-
0021331729
-
Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I
-
McVicar JP, Kunitake ST, Hamilton RL, Kane JP. Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I. Proc Natl Acad Sci USA 1984; 81: 1356-60.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 1356-1360
-
-
McVicar, J.P.1
Kunitake, S.T.2
Hamilton, R.L.3
Kane, J.P.4
-
74
-
-
0028271643
-
Identification of proteins associated with apolipoprotein A-Icontaining lipoproteins purified by selected-affinity immunosorption
-
Kunitake ST, Carilli CT, Lau K, Protter AA, Naya-Vigne J, Kane JP. Identification of proteins associated with apolipoprotein A-Icontaining lipoproteins purified by selected-affinity immunosorption. Biochemistry 1994; 33: 1988-93.
-
(1994)
Biochemistry
, vol.33
, pp. 1988-1993
-
-
Kunitake, S.T.1
Carilli, C.T.2
Lau, K.3
Protter, A.A.4
Naya-Vigne, J.5
Kane, J.P.6
-
75
-
-
77950894330
-
The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar highdensity lipoprotein cholesterol to remove cholesterol from macrophages
-
de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar highdensity lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010; 30: 796-801.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 796-801
-
-
de la Llera-Moya, M.1
Drazul-Schrader, D.2
Asztalos, B.F.3
Cuchel, M.4
Rader, D.J.5
Rothblat, G.H.6
-
76
-
-
0033670164
-
Distribution of ApoA-Icontaining HDL subpopulations in patients with coronary heart disease
-
Asztalos BF, Roheim PS, Milani RL, et al. Distribution of ApoA-Icontaining HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2670-6.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 2670-2676
-
-
Asztalos, B.F.1
Roheim, P.S.2
Milani, R.L.3
-
77
-
-
0025848995
-
Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease
-
Cheung MC, Brown BG, Wolf AC, Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 1991; 32: 383-94.
-
(1991)
J Lipid Res
, vol.32
, pp. 383-394
-
-
Cheung, M.C.1
Brown, B.G.2
Wolf, A.C.3
Albers, J.J.4
-
78
-
-
0034680309
-
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
-
Sacks FM, Alaupovic P, Moye LA, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 2000; 102: 1886-92.
-
(2000)
Circulation
, vol.102
, pp. 1886-1892
-
-
Sacks, F.M.1
Alaupovic, P.2
Moye, L.A.3
-
79
-
-
77952543789
-
HDL in humans with cardiovascular disease exhibits a proteomic signature
-
Vaisar T, Mayer P, Nilsson E, Zhao XQ, Knopp R, Prazen BJ. HDL in humans with cardiovascular disease exhibits a proteomic signature. Clin Chim Acta 2010; 411: 972-9.
-
(2010)
Clin Chim Acta
, vol.411
, pp. 972-979
-
-
Vaisar, T.1
Mayer, P.2
Nilsson, E.3
Zhao, X.Q.4
Knopp, R.5
Prazen, B.J.6
-
80
-
-
53449083547
-
Combined statin and niacin therapy remodels the high-density lipoprotein proteome
-
Green PS, Vaisar T, Pennathur S, et al. Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Circulation 2008; 118: 1259-67.
-
(2008)
Circulation
, vol.118
, pp. 1259-1267
-
-
Green, P.S.1
Vaisar, T.2
Pennathur, S.3
-
81
-
-
34047183679
-
CETP inhibitors to increase HDL cholesterol levels
-
Tall AR. CETP inhibitors to increase HDL cholesterol levels. N Engl J Med 2007; 356: 1364-6.
-
(2007)
N Engl J Med
, vol.356
, pp. 1364-1366
-
-
Tall, A.R.1
-
82
-
-
33646409606
-
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE-and ABCG1-dependent pathway
-
Matsuura F, Wang N, Chen W, Jiang XC, Tall AR. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE-and ABCG1-dependent pathway. J Clin Invest 2006; 116: 1435-42.
-
(2006)
J Clin Invest
, vol.116
, pp. 1435-1442
-
-
Matsuura, F.1
Wang, N.2
Chen, W.3
Jiang, X.C.4
Tall, A.R.5
-
83
-
-
34247352806
-
Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL
-
Yvan-Charvet L, Matsuura F, Wang N, et al. Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL. Arterioscler Thromb Vasc Biol 2007; 27: 1132-8.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1132-1138
-
-
Yvan-Charvet, L.1
Matsuura, F.2
Wang, N.3
-
85
-
-
78650054881
-
Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport
-
Niesor EJ, Magg C, Ogawa N, et al. Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport. J Lipid Res 2010; 51: 3443-54.
-
(2010)
J Lipid Res
, vol.51
, pp. 3443-3454
-
-
Niesor, E.J.1
Magg, C.2
Ogawa, N.3
-
86
-
-
34347377132
-
Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring
-
Heller M, Schlappritzi E, Stalder D, Nuoffer JM, Haeberli A. Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring. Mol Cell Proteomics 2007; 6: 1059-72.
-
(2007)
Mol Cell Proteomics
, vol.6
, pp. 1059-1072
-
-
Heller, M.1
Schlappritzi, E.2
Stalder, D.3
Nuoffer, J.M.4
Haeberli, A.5
-
87
-
-
55349134214
-
The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline
-
Paulovich AG, Whiteaker JR, Hoofnagle AN, Wang P. The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin Appl 2008; 2: 1386-402.
-
(2008)
Proteomics Clin Appl
, vol.2
, pp. 1386-1402
-
-
Paulovich, A.G.1
Whiteaker, J.R.2
Hoofnagle, A.N.3
Wang, P.4
-
89
-
-
33645721632
-
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
-
Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006; 5: 573-88.
-
(2006)
Mol Cell Proteomics
, vol.5
, pp. 573-588
-
-
Anderson, L.1
Hunter, C.L.2
-
90
-
-
0037795741
-
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
-
Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA 2003; 100: 6940-5.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 6940-6945
-
-
Gerber, S.A.1
Rush, J.2
Stemman, O.3
Kirschner, M.W.4
Gygi, S.P.5
-
91
-
-
33644524918
-
Mass spectrometry-based proteomics turns quantitative
-
Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005; 1: 252-62.
-
(2005)
Nat Chem Biol
, vol.1
, pp. 252-262
-
-
Ong, S.E.1
Mann, M.2
-
92
-
-
76649109590
-
An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers
-
Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics 2010; 9: 184-96.
-
(2010)
Mol Cell Proteomics
, vol.9
, pp. 184-196
-
-
Whiteaker, J.R.1
Zhao, L.2
Anderson, L.3
Paulovich, A.G.4
|